If a return to normalcy depends on finding a cure for COVID-19, then there needs to be a fast-tracked vaccine development process, albeit one without shortcuts. Patient participation across the spectrum of clinical development is key to this. As of June 2, 2020, the World Health Organization’s draft landscape of COVID-19 candidate vaccines listed 10 in clinical evaluation (phases 1–3 ) and 123 more in preclinical evaluation. The gold standard for clinical tr...